SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-014576
Filing Date
2020-12-30
Accepted
2020-12-30 16:07:27
Documents
12
Period of Report
2020-12-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neos-20201229x8k.htm   iXBRL 8-K 46141
  Complete submission text file 0001558370-20-014576.txt   169033

Data Files

Seq Description Document Type Size
2 EX-101.SCH neos-20201229.xsd EX-101.SCH 3235
3 EX-101.LAB neos-20201229_lab.xml EX-101.LAB 16159
4 EX-101.PRE neos-20201229_pre.xml EX-101.PRE 10955
5 EXTRACTED XBRL INSTANCE DOCUMENT neos-20201229x8k_htm.xml XML 4903
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37508 | Film No.: 201425939
SIC: 2834 Pharmaceutical Preparations